# Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

Study · id `cardio:ct-nct07734792` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07734792](<https://clinicaltrials.gov/study/NCT07734792>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07734792

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 726 participants.

## Technical summary

Registry record NCT07734792. Randomized; single masking; primary purpose treatment. Start 2026-09-26 (actual); primary completion 2028-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 726 participants (planned count; ClinicalTrials.gov record NCT07734792, source copy `cardio:ctgov-nct07734792-2026-11-12`, retrieved 2026-11-18)
- Started: 2026-09-26 (actual) (ClinicalTrials.gov record NCT07734792, source copy `cardio:ctgov-nct07734792-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2028-05-31 (anticipated) (ClinicalTrials.gov record NCT07734792, source copy `cardio:ctgov-nct07734792-2026-11-12`, retrieved 2026-11-18)
- Completion: 2028-07-31 (anticipated) (ClinicalTrials.gov record NCT07734792, source copy `cardio:ctgov-nct07734792-2026-11-12`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07734792, source copy `cardio:ctgov-nct07734792-2026-11-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07734792-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
- Acronym: TOPAZ
- Condition: Acute Ischemic Stroke (AIS)
- Intervention (Drug): Tirzepatide
- Intervention (Other): Standard Medical Care (SMC)
- Lead sponsor: yifang zhu
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tirzepatide (`cardio:tirzepatide`)
- Registry intervention is a member of this class by a sourced record link: GLP-1 receptor agonists (drug class) (`cardio:glp1-receptor-agonists`)

## Provenance

Content hash: 4e1f844ad57f8860dae870b1f64c71ed45d1c68fcc4061fa550f9d5c995e028a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
